16 Apr 2026Open access
Anti-arthritic efficacy of geraniol and methotrexate via miRNA-driven NLRP3 inflammasome suppression in rat adjuvant-induced arthritisPublisher siteInflammopharmacology, Inflammasome and immune disorders
UniversitiesMaged W. Helmy
Active, last published 2026
Maged W.
Helmy
Scholar“Research profile drawn from open scholarly records.”
Damanhour University
Claim Your Profile8
H-index
144
Citations
Maged has not officially claimed their profile. If you are Maged, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
research summary for Maged W. Helmy will appear here once their profile is updated.
02 · Reach
Publication output and reach
Maged's work has been cited 144 times across 5 active years. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
04 · Where I am
Affiliations
Affiliation on published researchDamanhour UniversityDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
28 works16 Apr 2026Open access
Innovative Berberine-Loaded Nanoparticle Vaginal Pessaries for Effective Vulvovaginitis TherapyPublisher siteJournal of Pharmaceutical Innovation, Advancements in Transdermal Drug Delivery
10 Apr 2026
Potential role of PVP/poloxamer 407 nanofibers loaded with resveratrol nanocrystals in skin cancer therapyPublisher siteJournal of drug targeting, Sirtuins and Resveratrol in Medicine
25 Feb 2026
Repurposing the antidepressant sertraline for colorectal cancer: Lactoferrin-functionalized TPGS-enhanced nanostructured lipid carriers in colon-targeted polymeric beadsPublisher siteJournal of Drug Delivery Science and Technology, Cancer, Stress, Anesthesia, and Immune Response
18 Feb 2026Open access
Sulfasalazine mitigates cisplatin-induced nephrotoxicity via NF-κB downregulation and upstream modulation of p-AMPK, SIRT1, miRNA-132-3p, and miRNA-375Publisher siteNaunyn-Schmiedeberg s Archives of Pharmacology, Chemotherapy-induced organ toxicity mitigation
18 Feb 2026Open access
Repurposing baricitinib and/or rosuvastatin to reinvigorate the anticancer immune response via suppressing PD-1/PD-L1 and CTLA-4 inhibitory immune checkpoints and correlated oncogenic pathways in lung cancer modelsPublisher siteFuture Journal of Pharmaceutical Sciences, Cancer, Lipids, and Metabolism
17 Feb 2026Open access
Effectiveness and safety of cyclosporine A in moderate to severe COVID-19: a randomized, open-label trialPublisher siteScientific Reports, COVID-19 Clinical Research Studies
13 Feb 2026
Synthesis, Nanoformulation, Molecular Modeling, and Anticancer Studies of 1,2,3-Triazole/Oxo-2-Thioxo-Thiazolidine Hybrids Using NF-κB and p-AMPK PathwaysPublisher sitePolycyclic aromatic compounds, Synthesis and biological activity
Expert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Maged?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you